Home Intro

Celldex is developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer.

Learn More

Our Science

Driven by our deep and longstanding experience developing antibody-based immunotherapies, Celldex’s proprietary antibody programs and technologies are supported by robust in-house capabilities, enabling the optimized discovery and development of innovative scientific programs.

Learn More

Image of people watching a presentation at a conference

Events & Presentations

View our upcoming events and recent presentations

Learn More
Image of scientist's hands in lab

Clinical Trials

For information on Celldex’s ongoing clinical studies, including information about how to enroll, please click here:

Learn More
image of scientist in lab


Celldex is always looking for passionate and talented individuals to join our team

Learn More